Krull, J. E., Wenzl, K., Hartert, K. T., Manske, M. K., Sarangi, V., Maurer, M. J., . . . Novak, A. J. (2020). Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients. Blood Cancer J.
Chicago Style CitationKrull, Jordan E., et al. "Somatic Copy Number Gains in MYC, BCL2, and BCL6 Identifies a Subset of Aggressive Alternative-DH/TH DLBCL Patients." Blood Cancer J 2020.
Cita MLAKrull, Jordan E., et al. "Somatic Copy Number Gains in MYC, BCL2, and BCL6 Identifies a Subset of Aggressive Alternative-DH/TH DLBCL Patients." Blood Cancer J 2020.
Atenció: Aquestes cites poden no estar 100% correctes.